Clinical trials
Recruiting Phase 2 Urinary Bladder Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
42 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 2 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 8 |
| 2025 | 14 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 42 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| Mayo Clinic | 2 |
| Rutgers, The State University of New Jersey | 2 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| AstraZeneca | 1 |
| Bayer | 1 |
| CG Oncology, Inc. | 1 |
| Changhai Hospital | 1 |
| City of Hope Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Neoplasms | 42 |
| Carcinoma, Transitional Cell | 7 |
| Ovarian Neoplasms | 7 |
| Breast Neoplasms | 5 |
| Non-Muscle Invasive Bladder Neoplasms | 5 |
| Colorectal Neoplasms | 4 |
| Pancreatic Neoplasms | 4 |
| Prostatic Neoplasms | 4 |
| Stomach Neoplasms | 4 |
| Carcinoma in Situ | 3 |
Trials
Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.